Miris Holding AB

Miris Holding is a biotechnology company that develops analytical instruments and consumables for human breast milk and fluids. The company has a particular focus on analyzing milk to provide proper nutrition to premature infants. The products are sold under separate brands and include a complete set of services and consumables. Miris operates on a global level, with headquarters based in Uppsala.

Quotes

Board

CEO

Marie Ekholm (tf)

Chairperson of the Board

Anders Hallberg

Board

Christian Wentzel
Erik Magnusson
Håkan Gill

Articles of association

Videos

1 / 3

CompanyPresentation VD Camilla Myhre Sandberg presenterar bolaget på Stora Aktiedagen i Göteborg

CompanyPresentation VD Camilla Myhre Sandberg presenterar bolaget hos Avanza

CompanyPresentation Bolagspresentation

** Powered by Modular Finance

*Powered by Modular Finance

Key Numbers

	2026-06-30	2026-03-31	2025-12-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Number of months that the report spans	Q2 3 Months	Q1 3 Months	2025	Q4 3 Months	Q3 3 Months	Q2 3 Months	Q1 3 Months
Total revenue MSEK	5.19	3.44	17.47	2.97	4.90	5.02	4.59
Earnings before interest and tax MSEK	-1.70	-2.38	-3.99	-1.28	-0.36	-0.69	-1.66
Profit before tax MSEK	-1.80	-2.48	-4.81	-1.36	-0.55	-0.97	-1.93
Net profit MSEK	-1.80	-2.48	-4.81	-1.36	-0.55	-0.97	-1.93
Earnings per share SEK	-1.35	-1.86	-0.02	-0.01	-0.00	-0.01	-0.01
Dividend per share SEK	0,00	0,00	0.00	0,00	0,00	0,00	0,00
Equity MSEK	15.82	17.62	20.13	20.13	21.57	-0.50	0.81
Fixed assets MSEK	0.07	0.08	0.00	0.00	0.00	0.00	0.00
Intangible assets MSEK	15.77	14.88	14.46	14.46	13.88	13.48	13.21
Current assets MSEK	11.55	12.19	15.87	15.87	20.34	9.71	8.40
Total asset MSEK	27.39	27.15	30.33	30.33	34.21	23.19	21.60
Long term liabilities MSEK	1.73	2.80	3.02	3.02	3.64	4.73	7.31
Current liabilities MSEK	8.96	6.73	7.19	7.19	8.10	18.97	13.49
Number of shares SEK	1332527.00	1332527.00	1332527.00	1332527.00	666263500.00	151567462.00	151567462.00